Potential Utility of Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and Neutrophil, Lymphocyte, and Platelet Ratios in Differential Diagnosis of Kidney Transplant Acute Rejection: A Retrospective, Propensity Score Matched Analysis

20 December 2022: Original Paper

Aureliusz Kolonko ^1ABCDEF* , Tomasz Dwulit ^1BDE , Michał Skrzypek ^2CDE , Andrzej Więcek ^1E

DOI: 10.12659/AOT.937239

Ann Transplant 2022; 27:e937239

Table 3 The results of univariate analysis for the occurrence of ABMR episode.

Variable	Odds ratio	Lower CL	Upper CL	p
Age	1.000	0.961	1.041	1.00
CIT	1.123	1.029	1.227	0.01
Retransplantation	3.846	1.254	11.796	0.02
ECD status	1.731	0.605	4.955	0.31
HLA mismatch	1.667	0.300	9.271	0.56
Bx NLR	1.028	0.996	1.060	0.09
Bx PLR	1.002	1.000	1.003	0.02
Bx N/LP	1.072	1.015	1.132	0.01
Bx-3 NLR	1.075	1.026	1.127	0.003
Bx-3 PLR	1.003	1.001	1.004	0.004
Bx-3 N/LP	1.128	1.049	1.213	0.001
ABMR – antibody-mediated rejection; CIT – cold ischemia time; ECD – extended criteria donor; HLA – human leukocyte antigen; Bx – the day of biopsy; NLR – neutrophil/lymphocyte ratio; PLR – platelet/lymphocyte ratio; N/LP – neutrophil/lymphocyte and platelet ratio, Bx-3 – 3 days prior to biopsy.